Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites.

Liu, Hong

Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites. [electronic resource] - Drug metabolism and disposition: the biological fate of chemicals 03 2017 - 294-305 p. digital

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

1521-009X

10.1124/dmd.116.071613 doi


Absorption, Physiological
Administration, Oral
Antineoplastic Agents--blood
Biotransformation
Bridged Bicyclo Compounds, Heterocyclic--blood
Feces--chemistry
Female
Healthy Volunteers
Humans
Proto-Oncogene Proteins c-bcl-2--antagonists & inhibitors
Sulfonamides--blood
Tissue Distribution